Clinical trial

A Study of the Effects of Giving Two Anti-HIV Vaccines to Babies of HIV-Positive…

NCT00000879 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed

Key facts

NCT number NCT00000879
Title A Study of the Effects of Giving Two Anti-HIV Vaccines to Babies of HIV-Positive Mothers
Official title A Phase I/II Study to Evaluate the Safety and Immunogenicity of ALVAC HIV Vaccines Alone and With AIDSVAX B/B in Children Born to HIV-Infected Mothers
Lead sponsor National Institute of Allergy and Infectious Diseases (NIAID), NIH
Collaborators Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH
Status Completed
Phase Phase 1
Study type Interventional
Conditions HIV Infections, HIV Seronegativity
Intervention type Biological
Interventions ALVAC(2)120(B, MN)GNP (vCP1452), MN rgp120/HIV-1 and GNE8 rgp120/HIV-1, ALVAC-HIV MN120TMG (vCP205)
Enrollment 48
Completion Apr 1, 2005
First posted Aug 31, 2001
Last update posted Oct 29, 2021
Countries United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies